[
  {
    "id": "recXOlSZvyEECnqkk",
    "Question": "Quel est le lien entre l'utilisation des antibiotiques et le traitement du COVID-19 ?",
    "Item status": "Published",
    "Category": "Traitement",
    "Sub-category": "A propps de : COVID-19 & antibiotiques",
    "Source of the question": [
      "Réseaux Sociaux"
    ],
    "Country question was sourced from": [
      "USA"
    ],
    "Background & context": "Les antibiotiques sont des médicaments antibactériens qui ralentissent ou détruisent la croissance des bactéries. Ils sont utilisés pour traiter les infections causées par des bactéries. Un article décrivant les différences entre les virus et les bactéries se trouve dans la section des ressources complémentaires. La maladie COVID-19 est causée par une infection par un virus, et non par une bactérie. COVID-19 est une maladie qui est un type de coronavirus. Les coronavirus sont un groupe de virus qui provoquent des maladies telles que le rhume, le syndrome respiratoire aigu sévère (SRAS) et le syndrome respiratoire du Moyen-Orient (SRM). Les virus et les bactéries étant différents, les maladies qu'ils provoquent ne peuvent pas être traitées par le même type de médicaments. Les antibiotiques ne peuvent pas être utilisés pour traiter des infections virales comme le COVID-19.  \n",
    "What our experts say": "Les antibiotiques ne sont certainement pas utilisés pour traiter ou guérir le COVID-19, mais ils peuvent traiter les infections bactériennes qui peuvent survenir à la suite de complications du virus COVID-19. Les virus et les infections bactériennes provoquent différents types de maladies, et les antibiotiques ne sont efficaces que pour traiter les infections bactériennes, et non les virus comme COVID-19. Les antibiotiques ne doivent pas être pris pour prévenir ou traiter COVID-19 et ils ne doivent pas être pris à moins d'être prescrits par un médecin. Parfois, les antibiotiques peuvent être utilisés chez les patients atteints de COVID-19, mais uniquement pour traiter des infections bactériennes secondaires. \n\n",
    "Glossary Terms": [
      "recRdDn65UcHnA63p",
      "recn0lT3zfEhVv8Eo",
      "recGkbysvb9KPYi3m"
    ],
    "Topics": [
      "antibiotiques",
      "infection bactérienne",
      "traitement",
      "cure"
    ],
    "Other resources": "1. Q&A on coronaviruses (COVID-19) ([WHO][1])\n2. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study ([The Lancet][2])   \n3. Rates of Co-infection Between SARS-CoV-2 and Other Respiratory Pathogens ([JAMA Network][3])\n4. Difference between a bacteria and a virus ([Mayo Clinic][4]) \n\n  [1]: https://www.who.int/news-room/q-a-detail/q-a-coronaviruses   http://www.med.umich.edu/asp/pdf/adult_guidelines/COVID-19-treatment.pdf\n  [2]: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30211-7/fulltext\n  [3]: https://jamanetwork.com/journals/jama/fullarticle/2764787\n  [4]: https://www.mayoclinic.org/diseases-conditions/infectious-diseases/expert-answers/infectious-disease/faq-20058098\n",
    "English Question": [
      "recu8V6IGjMveS5Ku"
    ],
    "Variation of the answer depending on country of residence": "Non\n",
    "Does this answer vary depending on your race, ethnicity, age, sex or other demographic factors?": "Non\n",
    "Last edited (simplified)": "2020-05-14T05:20:02.000Z",
    "Last edited (experts say)": "2020-05-14T05:21:40.000Z",
    "Last modified": "2020-05-15",
    "English Glossary": [
      "reco5k0tpirgGDeqb",
      "recnFUXyIZy81Rj1I",
      "rechTyFW9yFtRWh8o",
      "recRGHDXxeEnXrS9t",
      "recAFuzwLppTBDIPe"
    ],
    "(EN) Tags": [
      "antibiotics",
      "bacterial infection",
      "prevention",
      "treatment",
      "virus",
      "medicine"
    ],
    "English Category": [
      "Treatment"
    ],
    "English subcategory": [
      "On: COVID-19 & antibiotics "
    ],
    "English source": [
      "Social Media"
    ],
    "English country": [
      "USA"
    ],
    "What experts say english": [
      "Antibiotics are not used to treat or cure COVID-19, but they can treat bacterial infections that can happen as a result of complications from the COVID-19 virus. Viruses and bacterial infections cause different types of illnesses, and antibiotics are only effective in treating bacterial infections, not viruses like COVID-19. Antibiotics should not be taken as a way to prevent or treat COVID-19 and they should not be taken unless prescribed by a doctor. Sometimes, antibiotics might be used in patients with COVID-19 but only to treat secondary bacterial infections. "
    ],
    "Background & context english": [
      "Antibiotics are antibacterial medications that either slow down or destroy the growth of bacteria. They are used to treat infections that are caused by bacteria. (More information on the differences between viruses and bacteria can be found in the additional resources section.) The COVID-19 disease is caused by an infection with a virus, not a bacteria. COVID-19 is a disease that is a type of coronavirus. Coronaviruses are a group of viruses that cause diseases such as the common cold, severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS). Because viruses and bacteria are different, the illnesses that they cause cannot be treated by the same type of medication. Antibiotics cannot be used to treat viral infections like COVID-19.  "
    ],
    "Other Resources (English)": [
      "1. Q&A on coronaviruses (COVID-19) (WHO)\n2. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study (The Lancet)   \n3. Rates of Co-infection Between SARS-CoV-2 and Other Respiratory Pathogens (JAMA Network)\n4. Difference between a bacteria and a virus (Mayo Clinic) "
    ]
  },
  {
    "id": "recAj0TYj97UNUWtk",
    "Question": "Que dit la science sur l'utilisation de l'hydroxychloroquine pour prévenir, traiter ou guérir le COVID-19 ?",
    "Item status": "Published",
    "Category": "Traitement",
    "Sub-category": "A propps de : COVID-19 & hydroxychloroquine",
    "Source of the question": [
      "Réseaux Sociaux"
    ],
    "Country question was sourced from": [
      "Inde"
    ],
    "Background & context": "L'hydroxycloroquine est un médicament actuellement prescrit pour prévenir ou traiter la malaria, une maladie infectieuse qui peut être transmise à l'homme par les moustiques. Il est également prescrit comme traitement de la polyarthrite rhumatoïde et du lupus, qui sont toutes les deux des maladies auto-immunes.\nFace à un virus inconnu et en l’absence de vaccin et de traitement spécifiques, une des stratégies thérapeutiques consiste à regarder parmi les médicaments déjà disponibles et cliniquement testés, si l’un d’entre eux est efficace. Leurs balances bénéfices/risques et leurs effets secondaires ayant déjà été étudiés (sans toutefois permettre l’impasse sur les tests de sécurité), cela pourrait accélérer la recherche. Parmi ceux-là : l’hydroxychloroquine. \nLors de la recherche de traitements pour COVID-19, l'hydroxychloroquine a été testée sur des patients. Cependant, les résultats de cette recherche n'ont jusqu'à présent pas permis de recommander l'hydroxychloroquine pour le traitement de la COVID-19. Dans certaines de ces études, des consequences négatives sur l'état des patients ont été observées en association  avec la prise d'hydroxychloroquine.\n",
    "What our experts say": "Les essais cliniques en cours testent l'efficacité et la sécurité de la chloroquine et de l'hydroxychloroquine comme traitements pour la COVID-19. Jusqu'à présent, les essais cliniques et les analyses scientifiques n'ont pas produit de preuves de haute qualité (données probantes) montrant l'efficacité de ces médicaments en tant que traitement, et certaines études ont même signalé des taux plus élevés d'événements indésirables (y compris des problèmes cardiaques) chez les patients hospitalisés traités à l'hydroxychloroquine. A l'heure actuelle, l'hydroxychloroquine n'est pas un moyen de prévention ni un traitement reconnu pour la COVID-19.\nDans ce contexte, des études sont en cours pour savoir si la prise de ce médicament en prévention peut empêcher les gens d'être infectés par le coronavirus s'ils sont exposés au virus ; d'autres études examinent encore son efficacité et sa sécurité en tant que traitement en fonction du degré de sévérité de la maladie, dans le cadre d'essais contrôlés randomisés avec un grand nombre de patients inscrits.\nA travers le monde, certains pays sont allés de l'avant et ont autorisé la chloroquine ou l'hydroxychloroquine pour le traitement du COVID-19, malgré le peu de preuves cliniques concernant son efficacité. Cette décision fait suite à des résultats préliminaires obtenus en Chine et en France en mars 2020, où quelques essais cliniques de petite taille ont montré que le médicament n'avait eu qu'un succès limité.\nAux États-Unis, l’agence de réglementation des produits biologiques (Food and Drug Administration-FDA), a accordé une autorisation spéciale pour utiliser la chloroquine et l'hydroxychloroquine dans les essais cliniques et les situations d'urgence relatives à la COVID-19. Ceci ne constitue pas une approbation formelle du médicament, mais plutôt une possibilité donnée aux médecins américains d'utiliser la chloroquine et l'hydroxychloroquine dans les essais cliniques et dans le traitement de COVID-19 si le médecin n'a pas d'autres options.\n\n",
    "Glossary Terms": [
      "recvR7KM6VedZfxmX",
      "recAvIYWiEsqWpO9E",
      "recid3z2x1uYoo6xq"
    ],
    "Topics": [
      "Hydroxychloroquine",
      "prévention",
      "traitement",
      "cure"
    ],
    "Other resources": "1. FDA cautions against the use of hydroxychloroquine or chloroquine for COVID-19 outside of the hospital setting or a clinical trial due to a risk of heart rhythm problems ([U.S. FDA][1])\n2. Investigational therapeutics for patients with COVID-19 ([U.S. CDC][2]) \n3. Trial update: No clinical benefit from use of hydroxychloroquine in hospitalized patients with COVID-19 ([Recovery Trial][3])\n4. Information about \"compassionate use\" ([U.S. FDA][4]) \n5. Research paper: A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19 ([NEJM][5])\n6. Hydroxychloroquine or Chloroquine for Treatment or Prophylaxis of COVID-19: A Living Systematic Review ([AIM][6])\n7. Research paper: Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial ([BMJ][7])\n8. Research paper: Association of Treatment With Hydroxychloroquine or Azithromycin With In-Hospital Mortality in Patients With COVID-19 in New York State ([JAMA][8])\n9. Research paper: Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19 ([NEJM][9])\n10. Research paper: Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial ([BMJ][7])\n\n  [1]: https://www.fda.gov/drugs/drug-safety-and-availability/fda-cautions-against-use-hydroxychloroquine-or-chloroquine-covid-19-outside-hospital-setting-or\n  [2]: https://www.cdc.gov/coronavirus/2019-ncov/hcp/therapeutic-options.html\n  [3]: https://www.recoverytrial.net/news/statement-from-the-chief-investigators-of-the-randomised-evaluation-of-covid-19-therapy-recovery-trial-on-hydroxychloroquine-5-june-2020-no-clinical-benefit-from-use-of-hydroxychloroquine-in-hospitalised-patients-with-covid-19\n  [4]: https://www.fda.gov/news-events/public-health-focus/expanded-access\n  [5]: https://www.nejm.org/doi/full/10.1056/NEJMoa2016638?query=featured_home\n  [6]: https://www.acpjournals.org/doi/10.7326/M20-2496\n  [7]: https://www.bmj.com/content/369/bmj.m1849\n  [8]: https://jamanetwork.com/journals/jama/fullarticle/2766117\n  [9]: https://www.nejm.org/doi/full/10.1056/NEJMoa2012410\n",
    "English Question": [
      "rechQWZ1ctlJ81Vxn"
    ],
    "Variation of the answer depending on country of residence": "Oui - certains pays ont inclus l'hydroxychloroquine dans leur protocole de traitement, bien que l'Organisation mondiale de la santé (OMS) ne reconnaisse pas ce médicament comme un traitement, car ils attendent les résultats des essais cliniques.\n",
    "Does this answer vary depending on your race, ethnicity, age, sex or other demographic factors?": "Non\n",
    "Last edited (simplified)": "2020-05-18T01:45:24.000Z",
    "Last edited (experts say)": "2020-05-26T23:04:11.000Z",
    "Last modified": "2020-07-07",
    "English Glossary": [
      "recM4p8QOERmuESKr",
      "recAiJYWSxD5F1Lz1",
      "recJ1c8DQQVGmXfzM",
      "recjILnexcCRlyBIb"
    ],
    "(EN) Tags": [
      "prevention",
      "treatment",
      "cure",
      "hydroxychloroquine"
    ],
    "English Category": [
      "Treatment"
    ],
    "English subcategory": [
      "On: COVID-19 & hydroxychloroquine"
    ],
    "English source": [
      "Social Media"
    ],
    "English country": [
      "India"
    ],
    "What experts say english": [
      "Ongoing clinical trials are testing how safe and effective chloroquine and hydroxychloroquine are as treatments for COVID-19. So far, clinical trials and scientific analyses have not produced high quality evidence showing efficacy of these medications as a treatment, and some studies have even reported higher rates of adverse events (including cardiac issues) in hospitalized patients treated with hydroxychloroquine. As things stand, hydroxychloroquine is not a recognized prevention, treatment or cure for COVID-19.\nIn this context, there are research studies underway to find out whether taking this medication can prevent people from getting infected with coronavirus once they have been exposed. Other studies are still investigating the efficacy and safety of the drug as a treatment at different stages of the illness, including randomized controlled trials with a large number of patients enrolled.\nAround the world, some countries have moved ahead and authorized chloroquine or hydroxychloroquine for the treatment of COVID-19 despite limited clinical evidence supporting its efficacy. This decision follows some preliminary results coming out of China and France in March 2020, where a few small clinical trials showed limited success of the medication.\nIn the Unites States, on March 27th 2020, the Food and Drug Administration (FDA) has granted a special permission (Emergency Authorization Use) to use chloroquine and hydroxychloroquine in emergency situations for treatment of COVID-19. This did not constitute a formal approval of the drug, but rather a possibility given to American doctors to use chloroquine and hydroxychloroquine in the treatment of COVID-19 if the doctor has no other options and after discussing with the patients the risks involved. On June 15th 2020, the U.S. FDA has revoked the special permission to use chloroquine and hydroxychloroquine in emergency situations for COVID-19 citing that these drugs are unlikely to be effective in treating COVID-19 and highlighting serious cardiac adverse events and other serious side effects reported in studies."
    ],
    "Background & context english": [
      "Hydroxycloroquine is a medication currently prescribed for preventing or treating malaria, an infectious disease that can be transmitted to humans from mosquitos. It is also prescribed as a treatment for rheumatoid arthritis and lupus, which are both autoimmune diseases.\nWhen faced with an unknown virus like COVID-19 and without a specific vaccine and treatment, one of the best medical strategies is to look among the medications already available and clinically tested to see if any of them are effective. As their risks, benefits, and side effects have already been studied (without allowing safety tests to be ignored), this could speed up research. One of these is hydroxychloroquine. \nWhen trying to find treatments for COVID-19, hydroxychloroquine was tested on hospitalized patients. However, the results from this research do not represent evidence significant enough to recommend hydroxychloroquine for treating COVID-19. At the same time, some research studies have also shown some serious negative consequences (incl. serious heart rhythm problems) associated with the use of hydroxychloroquine in the treatment of COVID-19. More studies are underway.\n"
    ],
    "Other Resources (English)": [
      "1. FDA revokes the emergency use authorization for chloroquine and hydroxychloroquine (U.S. FDA)\n2. FDA cautions against the use of hydroxychloroquine or chloroquine for COVID-19 outside of the hospital setting or a clinical trial due to a risk of heart rhythm problems (U.S. FDA)\n3. Investigational therapeutics for patients with COVID-19 (U.S. CDC) \n4. Research Update: Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19 (AIM)\n5. Trial update: Effect of Hydroxychloroquine in Hospitalized Patients with COVID-19: Preliminary results from a multi-centre, randomized, controlled trial. (medRxiv)\n6. Trial update: No clinical benefit from use of hydroxychloroquine in hospitalized patients with COVID-19 (Recovery Trial)\n7. Information about \"compassionate use\" (U.S. FDA) \n8. Research paper: A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19 (NEJM)\n9. Hydroxychloroquine or Chloroquine for Treatment or Prophylaxis of COVID-19: A Living Systematic Review (AIM)\n10. Research paper: Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial (BMJ)\n11. Research paper: Association of Treatment With Hydroxychloroquine or Azithromycin With In-Hospital Mortality in Patients With COVID-19 in New York State (JAMA)\n12. Research paper: Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19 (NEJM)\n13. Research paper: Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial (BMJ)\n"
    ]
  },
  {
    "id": "recbjW2CdPdJHM0wE",
    "Question": "Quelles sont les origines du virus ?",
    "Item status": "Published",
    "Category": "Origines",
    "Sub-category": "A propps de : COVID-19 & origines",
    "Source of the question": [
      "Réseaux Sociaux"
    ],
    "Country question was sourced from": [
      "Inde",
      "Kenya",
      "USA"
    ],
    "Background & context": "Les coronavirus sont un groupe de virus qui peuvent causer une variété de maladies différentes. Ces maladies comprennent le rhume, le syndrome respiratoire aigu sévère (SRAS) et le syndrome respiratoire du Moyen-Orient (MERS). Certains virus peuvent provenir d'animaux et infecter ensuite l'humain, et cela peut se produire de différentes manières, notamment : en mangeant de la viande ou des produits qui ont été contaminés par le virus, par voie aérienne ou en touchant une surface qui a été touchée par un animal infecté, par un contact étroit avec un animal infecté ou par des piqûres d'insectes. Tous les virus ne se transmettent pas des animaux à l'humain par ces voies, cela dépend du virus. La section \"Ressources\" contient plus d'informations à ce sujet. \n",
    "What our experts say": "Le COVID-19 a été détecté pour la première fois dans la ville de Wuhan, en Chine, fin 2019. Le virus a depuis été partiellement retracé jusqu'à un grand marché de fruits de mer et d'animaux dans la ville, après que plusieurs personnes qui s'étaient rendues au marché aient été malades de la maladie que nous connaissons maintenant sous le nom de COVID-19. Les scientifiques ont pu analyser le génome du virus pour confirmer que le virus avait été identifié pour la première fois dans des échantillons humains et environnementaux dans la ville de Wuhan. Lorsque ces analyses génomiques ont été effectuées sur les gènes du virus COVID-19, ils ont révélé que le virus provenait d'un animal infecté et que le virus a muté lorsque cet animal a transféré le virus à un humain, probablement au grand marché de fruits de mer et d'animaux de Wuhan. Les détails de cet événement, appelé \"transfert zoonotique\", sont toujours en cours d'investigation.\n\n",
    "Glossary Terms": [
      "reccwo5NJI2cHb2Wl",
      "recbMekD6UXPWJAi6"
    ],
    "Topics": [
      "origines",
      "Wuhan",
      "Chine",
      "chauve souris"
    ],
    "Other resources": "1. Genomic analysis findings for origin of COVID-19 ([NIH][1]) \n2. Zoonotic diseases description ([CDC][2]) \n3. Background on COVID-19 origin ([CDC][3]) \n4. COVID-19 information page ([CDC][4]) \n5. Research article: COVID-19: a novel zoonotic disease caused by a coronavirus from China: what we know and what we don’t ([NCBI][5])\n\n  [1]: https://directorsblog.nih.gov/2020/03/26/genomic-research-points-to-natural-origin-of-covid-19/\n  [2]: https://www.cdc.gov/onehealth/basics/zoonotic-diseases.html\n  [3]: https://emergency.cdc.gov/han/han00426.asp\n  [4]: https://www.cdc.gov/media/dpk/diseases-and-conditions/coronavirus/coronavirus-2020.html\n  [5]: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7086482/#R1\n",
    "English Question": [
      "recqFRWiE9Y6nbUM5"
    ],
    "Variation of the answer depending on country of residence": "Non\n",
    "Does this answer vary depending on your race, ethnicity, age, sex or other demographic factors?": "Non\n",
    "Last edited (simplified)": "2020-05-15T00:13:36.000Z",
    "Last edited (experts say)": "2020-05-15T00:11:43.000Z",
    "Last modified": "2020-05-15",
    "Frequency of update": [
      "Monthly"
    ],
    "English Glossary": [
      "recbQ95pvRq7nP9s3",
      "recFSOdDjQBqJHnZ9"
    ],
    "(EN) Tags": [
      "origin",
      "bats",
      "Wuhan",
      "China"
    ],
    "English Category": [
      "Origin"
    ],
    "English subcategory": [
      "On: The origin of COVID-19 "
    ],
    "English source": [
      "Social Media"
    ],
    "English country": [
      "India",
      "Kenya",
      "USA"
    ],
    "What experts say english": [
      "COVID-19 was first detected in the city of Wuhan, China in late 2019. The virus has since been partially traced back to a large seafood and animal market in the city of Wuhan, after several people who had been to the market became sick with the illness we now know as COVID-19. Scientists were able to use genetic tests to confirm that the virus was first identified in people and environmental samples in the city of Wuhan. Tests on the genetics of viruses, much like genetics in humans, can reveal a lot about their origins. When these genetic tests were done on the COVID-19 virus' genes, it revealed that the virus originated in an infected animal and mutated when that animal transferred the virus to a human, likely in the city of Wuhan. The details about that event, which is called a zoonotic transfer, are still being investigated.\n\n"
    ],
    "Background & context english": [
      "Coronaviruses are a group of viruses that can cause a variety of different illnesses, but primarily upper-respiratory tract illnesses in humans. These illnesses include the common cold, severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS). Some viruses can originate in animals and later infect humans, and this can happen in a number of different ways, including: by eating meat or produce that has been contaminated by the virus, through the air or by touching a surface that was touched by an infected animal, through close contact with an infected animal, or through insect bites. Not all viruses transfer from animals to humans in all of these ways, it depends on the virus. The resources section contains more information about this. \n"
    ],
    "Other Resources (English)": [
      "1. Viral and host factors related to the clinical outcome of COVID-19 (Nature)\n2. Genomic Study Points to Natural Origin of COVID-19 (NIH) \n3. Zoonotic diseases (U.S. CDC) \n4. Update and Interim Guidance on Outbreak of 2019 Novel Coronavirus (2019-nCoV) in Wuhan, China (U.S. CDC) \n5. Coronavirus Disease 2019 (COVID-19) (U.S. CDC) \n6. COVID-19: a novel zoonotic disease caused by a coronavirus from China: what we know and what we don’t (NCBI)\n"
    ]
  },
  {
    "id": "reccy9EmiOk9SlhJ7",
    "Question": "Le COVID-19 peut-il être transmis par une personne qui ne présente aucun symptôme ?",
    "Item status": "Published",
    "Category": "Transmission",
    "Sub-category": "A propps de : transmission du COVID-19 sans présentation de symptômes",
    "Source of the question": [
      "Réseaux Sociaux"
    ],
    "Country question was sourced from": [
      "USA"
    ],
    "Background & context": "La période d'incubation du virus est la période de temps qui s'écoule entre le moment où une personne est infectée par le virus et celui où elle présente ses premiers symptômes. Pendant cette période, le virus se multiplie dans l'organisme, et une fois qu'il s'est suffisamment reproduit, les gens peuvent effectivement présenter des symptômes. \n",
    "What our experts say": "Oui. Selon les preuves actuelles, on pense que les personnes ne présentant aucun symptôme, qui peuvent être asymptomatiques ou présymptomatiques, jouent un rôle majeur dans la transmission de COVID-19. Cela signifie qu'un dépistage basé sur les symptômes à lui seul a peu de chances de détecter tous les cas infectieux et de contrôler la transmission de COVID-19.La \"période d'incubation\" de COVID-19, qui est la période entre l'exposition d'une personne au virus et le premier signe de ses symptômes (si elle en développe), va de 5 à 14 jours. Certaines personnes peuvent être contagieuses pendant cette période d'incubation de 5 à 14 jours avant d'avoir des symptômes, ce qui rend ces cas \"pré-symptomatiques\". D'autres peuvent ne jamais présenter de symptômes du tout et sont dites \"asymptomatiques\". Les personnes asymptomatiques sont toujours contagieuses pendant toute la période où elles sont infectées par le virus, jusqu'à ce que leur corps élimine le virus.\n",
    "Glossary Terms": [
      "rec5NviyR1bKlIVTa",
      "recdwSm7f3It0F5Eq",
      "rec4IrZTOe3lpz98t",
      "recxD9dPlL1W8DCs2"
    ],
    "Topics": [
      "asymptomatique",
      "transmission",
      "propagation",
      "infection",
      "symptômes"
    ],
    "Other resources": "1. COVID-19 situation report ([WHO][1]) \n2. Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility ([NEJM][2])\n3. Research letter: Asymptomatic SARS-CoV-2 Infection in Household Contacts of a Healthcare Provider, Wuhan, China ([U.S. CDC][3])\n4. A study about RT-PCR COVID-19 tests and their false-negative rate ([AIM][4])\n5. Research paper: The airborne lifetime of small speech droplets and their potential importance in SARS-CoV-2 transmission ([PNAS][5])\n6. CDC Pandemic Planning Scenarios ([CDC][6])\n\n  [1]: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200402-sitrep-73-covid-19.pdf\n  [2]: https://www.nejm.org/doi/full/10.1056/NEJMoa2008457\n  [3]: https://wwwnc.cdc.gov/eid/article/26/8/20-1016_article\n  [4]: https://www.acpjournals.org/doi/10.7326/M20-1495#.XrxprFvK46Y.twitter\n  [5]: https://www.pnas.org/content/early/2020/05/12/2006874117\n  [6]: https://www.cdc.gov/coronavirus/2019-ncov/hcp/planning-scenarios.html\n",
    "English Question": [
      "recSK7NRoa33YUdrv"
    ],
    "Variation of the answer depending on country of residence": "Non\n",
    "Does this answer vary depending on your race, ethnicity, age, sex or other demographic factors?": "Non\n",
    "Last edited (simplified)": "2020-05-14T23:24:52.000Z",
    "Last edited (experts say)": "2020-05-14T04:02:29.000Z",
    "Last modified": "2020-07-13",
    "Frequency of update": [
      "Monthly"
    ],
    "English Glossary": [
      "recE7xmnXgtg8ZanX",
      "recJ4Q812SOdo1NGM",
      "recx2PeCcs1Awb9rG",
      "rec8po7cJXvqkaQYB",
      "recbZcFUtsYMA9Vsh"
    ],
    "(EN) Tags": [
      "asymptomatic",
      "transmission",
      "contagion",
      "infection",
      "spread",
      "symptoms"
    ],
    "English Category": [
      "Spread"
    ],
    "English subcategory": [
      "On: COVID-19 & asymptomatic & pre-symptomatic transmission"
    ],
    "English source": [
      "Social Media"
    ],
    "English country": [
      "USA"
    ],
    "What experts say english": [
      "According to current evidence, it is believed that people with no symptoms, who may be either asymptomatic or pre-symptomatic, are playing a major role in the transmission of COVID-19. That means symptom-based screening alone is unlikely to detect all of the infectious cases and control the transmission of COVID-19. The incubation period of COVID-19, which is the period between a person's exposure to the virus and the first sign of their symptoms (if they develop any at all), ranges from 5 to 14 days. Some people may be contagious during this 5-14 day incubation period before they have symptoms, making those cases \"pre-symptomatic\". The Centers for Disease Control (CDC) has stated that 40% of COVID-19 cases are potentially spread by people who are pre-symptomatic. Other people infected with COVID-19 may never show symptoms at all and are called \"asymptomatic\". Asymptomatic people are still contagious throughout the time they are infected with the virus until their body clears it. The CDC estimates that 35% of COVID-19 cases are asymptomatic."
    ],
    "Background & context english": [
      "The incubation period of the virus is the time between the moment a person is exposed to the virus and when they first show symptoms. During this period, the virus is multiplying in the body, and once enough of the virus has been replicated, people may indeed show symptoms. However, some people may well be infected with the virus even if they don't have any symptoms. For people who are pre-symptomatic and asymptomatic, they may still spread the virus to others during this period of time."
    ],
    "Other Resources (English)": [
      "1. COVID-19 situation report (WHO) \n2. Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility (NEJM)\n3. Research letter: Asymptomatic SARS-CoV-2 Infection in Household Contacts of a Healthcare Provider, Wuhan, China (U.S. CDC)\n4. A study about RT-PCR COVID-19 tests and their false-negative rate (AIM)\n5. Research paper: The airborne lifetime of small speech droplets and their potential importance in SARS-CoV-2 transmission (PNAS)\n6. CDC Pandemic Planning Scenarios (U.S. CDC)"
    ],
    "Change notes": [
      "Okay I changed thhis detail"
    ]
  },
  {
    "id": "recpBz5mkWp9d4kae",
    "Question": "Le retour de l'été et de la chaleur va-t-il freiner la propagation du coronavirus ?",
    "Item status": "Published",
    "Category": "Transmission",
    "Sub-category": "A propps de : transmission du COVID-19 pendant l'été",
    "Source of the question": [
      "Organisation de fact-checking"
    ],
    "Country question was sourced from": [
      "Inde"
    ],
    "Background & context": "Certains virus, comme le rhume et la grippe, se propagent davantage lorsque le temps est plus froid. Les chercheurs ont étudié comment la température et l'humidité pouvaient influencer la propagation d'autres virus, mais il n'y a aucune preuve d'un tel impact dans le contexte de COVID-19. \n",
    "What our experts say": "La science n'est pas sûre que la propagation de COVID-19 diminuera pendant les mois d'été les plus chauds. Certains virus, comme ceux qui causent le rhume et la grippe, ne se propagent pas aussi facilement quand il fait chaud. À l'heure actuelle, nous ne savons pas avec certitude si la propagation de COVID-19 diminuera lorsque le temps se réchauffera. \n",
    "Glossary Terms": [
      "recN1KGOfbDmvsGiU"
    ],
    "Topics": [
      "variabilité saisonnière",
      "infection"
    ],
    "Other resources": "1. COVID-19 Resource Center ([Harvard][1]) \n2. Will warm weather slow spread of novel coronavirus? ([NIH][2])\n\n  [1]: https://www.health.harvard.edu/diseases-and-conditions/coronavirus-resource-center\n  [2]: https://directorsblog.nih.gov/2020/06/02/will-warm-weather-slow-spread-of-novel-coronavirus/\n",
    "English Question": [
      "recOiBtU1KHxAQAgq"
    ],
    "Variation of the answer depending on country of residence": "Non\n",
    "Does this answer vary depending on your race, ethnicity, age, sex or other demographic factors?": "Non\n",
    "Last edited (simplified)": "2020-05-14T04:14:03.000Z",
    "Last edited (experts say)": "2020-05-14T04:17:28.000Z",
    "Last modified": "2020-06-03",
    "English Glossary": [
      "recDalYrz2m23kS2e"
    ],
    "(EN) Tags": [
      "summer transmission",
      "infection",
      "seasonality",
      "trends",
      "patterns"
    ],
    "English Category": [
      "Spread"
    ],
    "English subcategory": [
      "On: COVID-19 transmission during the summer"
    ],
    "English source": [
      "Fact-checking organization"
    ],
    "English country": [
      "India"
    ],
    "What experts say english": [
      "The science is unclear on whether the spread of COVID-19 will decrease in the warmer summer months. Some viruses, like those that cause the common cold and flu, don't spread as easily in warm weather. We don't know for sure how COVID-19 will react to changing temperatures. At this stage, temperature-related transmission reductions are hypothetical."
    ],
    "Background & context english": [
      "Some viruses, such as the common cold and flu, have historically spread faster when the weather is colder. Researchers have investigated how the spread of other viruses might be influenced by temperature and humidity, but there is no evidence of such an impact in the context of COVID-19 so far. "
    ],
    "Other Resources (English)": [
      "1. COVID-19 Resource Center (Harvard) \n2. Will warm weather slow spread of novel coronavirus? (U.S. NIH)"
    ]
  },
  {
    "id": "recD1hQ5hwPZnyPCX",
    "Question": "Quel est l'impact de la vitamine C sur la COVID-19 ?",
    "Item status": "Published",
    "Category": "Traitement, Cure, Prévention",
    "Sub-category": "A propps de : COVID-19 & vitamine C",
    "Source of the question": [
      "Réseaux Sociaux",
      "Salle de rédaction"
    ],
    "Country question was sourced from": [
      "USA",
      "Canada",
      "Afrique du Sud"
    ],
    "Background & context": "La vitamine C est une vitamine naturellement présente dans certains aliments, et qui est ajoutée à d'autres. La consommation de vitamine C est importante car, bien que l'organisme en ait besoin pour diverses raisons, ce n'est pas quelque chose que le corps humain peut facilement fabriquer par lui-même. Vous trouverez plus d'informations à ce sujet dans la section des ressources supplémentaires. \n",
    "What our experts say": "La vitamine C ne peut pas vous empêcher de tomber malade ou de contracter le COVID-19. Elle n'est ni un remède ni une méthode de prévention du virus. Contrairement à la croyance populaire, il n'a jamais été prouvé que la vitamine C régulière diminue le nombre de rhumes contractés. Elle pourrait contribuer à réduire la durée et la gravité des rhumes, mais même les recherches dans ce domaine ne sont pas encore claires et évoluent. Actuellement, des études menées dans le monde entier tentent de déterminer si la vitamine C pourrait aider les personnes atteintes de COVID-19, mais aucune preuve ne montre que la prise de vitamine C peut avoir un impact sur les personnes atteintes du virus.\n",
    "Glossary Terms": [
      "recCMLHJbe4MXCiEp"
    ],
    "Topics": [
      "Vitamin C"
    ],
    "Other resources": "1. Debunk of COVID-19 myths around the use of supplements ([Mayo Clinic][1]) \n2. Research paper: Vitamin C and the common cold ([NCBI][2])  \n3. Research paper: Vitamin C and the immune system ([NCBI][3]) \n4. General information about Vitamin C ([Mayo Clinic][4]) \n\n  [1]: https://www.mayoclinic.org/diseases-conditions/coronavirus/in-depth/coronavirus-myths/art-20485720\n  [2]: https://www.ncbi.nlm.nih.gov/pubmed/23440782\n  [3]: https://www.ncbi.nlm.nih.gov/pubmed/29099763\n  [4]: https://www.mayoclinic.org/drugs-supplements-vitamin-c/art-20363932\n",
    "English Question": [
      "recQZ5Gya03eOGb8l"
    ],
    "Variation of the answer depending on country of residence": "Non\n",
    "Does this answer vary depending on your race, ethnicity, age, sex or other demographic factors?": "Non\n",
    "Last edited (simplified)": "2020-05-14T04:27:03.000Z",
    "Last edited (experts say)": "2020-05-14T16:17:43.000Z",
    "Last modified": "2020-07-13",
    "English Glossary": [
      "recOMUWrX4F2d53iC"
    ],
    "(EN) Tags": [
      "vitamin C",
      "immune system",
      "prevention"
    ],
    "English Category": [
      "Treatment, Cure, Prevention"
    ],
    "English subcategory": [
      "On: COVID-19 & vitamin C"
    ],
    "English source": [
      "Newsroom",
      "Social Media"
    ],
    "English country": [
      "USA",
      "Canada",
      "South Africa"
    ],
    "What experts say english": [
      "Vitamin C cannot prevent you from getting sick or from contracting COVID-19. It is neither a cure nor a prevention method for the virus. Contrary to popular belief, regular Vitamin C has never been proven to lower the number of colds people contract. It might help reduce the length of time someone is sick with a cold, as well as the severity of a cold, but even the research on that is still unclear and evolving. Right now, studies around the world are trying to determine if Vitamin C might help people with COVID-19, but no evidence shows that taking Vitamin C can impact people who have the virus."
    ],
    "Background & context english": [
      "Vitamin C is a vitamin that is naturally present in some foods, and is added to others. Consuming Vitamin C is important because, though the body needs it for a variety of reasons, it is not something that the human body can readily make on its own. More information about this is available in the additional resources section. "
    ],
    "Other Resources (English)": [
      "1. Debunking COVID-19 (coronavirus) myths (Mayo Clinic) \n2. Vitamin C for Preventing and Treating the Common Cold (NCBI)  \n3. Vitamin C and Immune Function (NCBI) \n4. Vitamin C (Mayo Clinic) \n"
    ]
  },
  {
    "id": "recjXAWxtpH214q4o",
    "Question": "Où en sont les recherches concernant la transmission sexuelle du COVID-19 ?",
    "Item status": "Published",
    "Category": "Transmission",
    "Sub-category": "A propps de : COVID-19 & transmission sexuelle",
    "Source of the question": [
      "Réseaux Sociaux"
    ],
    "Country question was sourced from": [
      "USA",
      "Mexique"
    ],
    "Background & context": "Les virus peuvent être transmis de différentes manières. Certains virus peuvent se propager par contact physique ou par le toucher, par les fluides corporels tels que la salive, ou par voie aérienne. D'autres virus peuvent être transmis par des piqûres de tiques ou de moustiques, qui sont porteurs du virus, ou par des aliments et de l'eau contaminés. D'autres virus peuvent être transmis par rapport sexuel ou par le partage d'aiguilles contaminées par des liquides corporels. \n",
    "What our experts say": "Sur la base des preuves disponibles actuellement, les experts ne savent pas si le COVID-19 peut se transmettre par des fluides corporels qui ne sont pas des fonctions respiratoires comme la toux et les éternuements. Nous savons, jusqu'à présent, que toutes les preuves indiquent une transmission par voie respiratoire. Aucun cas de transmission sexuelle n'a été documenté à ce jour. Une certaine confusion à ce sujet pourrait être due au fait que des traces du virus qui provoque la COVID-19 ont été trouvées dans les échantillons de sperme de 6 des 38 hommes qui ont fourni des échantillons dans le cadre d'une étude de recherche. Selon l'étude, quatre des six hommes étaient toujours infectés, tandis que deux se rétablissaient. Cela ne signifie pas que la COVID-19 est sexuellement transmissible. Des traces du virus ont également été trouvées dans d'autres fluides corporels et dans des échantillons de selles, mais il n'est pas certain que le virus puisse se transmettre lors de rapports sexuels.\n",
    "Glossary Terms": [
      "recxD9dPlL1W8DCs2"
    ],
    "Topics": [
      "sperme",
      "transmission sexuelle",
      "MST",
      "IST"
    ],
    "Other resources": "1. Research paper: A study to examine the prevalence of SARS-CoV-2, the virus responsible for COVID-19, in semen ([JAMA][1]) \n\n  [1]: https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2765654\n",
    "English Question": [
      "recllQqVLGnigxKql"
    ],
    "Variation of the answer depending on country of residence": "Non\n",
    "Does this answer vary depending on your race, ethnicity, age, sex or other demographic factors?": "Non\n",
    "Last edited (simplified)": "2020-05-14T23:30:47.000Z",
    "Last edited (experts say)": "2020-05-14T23:31:43.000Z",
    "Last modified": "2020-05-15",
    "English Glossary": [
      "rec2UNEXbTkSCx30Q"
    ],
    "(EN) Tags": [
      "semen",
      "COVID-19",
      "sexual transmission",
      "STD",
      "STI"
    ],
    "English Category": [
      "Transmission"
    ],
    "English subcategory": [
      "On: COVID-19 & sexual transmission"
    ],
    "English source": [
      "Social Media"
    ],
    "English country": [
      "USA",
      "Mexico"
    ],
    "What experts say english": [
      "There have been no documented cases of sexual transmission. Based on the evidence available right now, experts do not know whether COVID-19 can spread from person to person through bodily fluids that are not respiratory functions like talking, coughing and sneezing. Some confusion around this could be because traces of the virus that causes COVID-19 were found in the semen samples of 6 out of 38 men who provided samples in a research study. According to the study, four of the six men were still infected, while two were recovering. This does not mean that COVID-19 is sexually transmitted. Traces of the virus have also been found in other bodily fluids and stool samples, but it is unclear whether the virus can spread from person to person through sexual transmission."
    ],
    "Background & context english": [
      "There are a number of different ways that viruses can be transmitted. Some viruses can spread through physical contact or touch, through bodily fluids such as the exchange of saliva, or through the air. Other viruses might be transmitted through bites from ticks or mosquitos, who carry the virus, or through food and water that are contaminated. Some other viruses can be shared through sexual contact, or by sharing needles that have been contaminated by bodily fluids. "
    ],
    "Other Resources (English)": [
      "1. Clinical Characteristics and Results of Semen Tests Among Men With Coronavirus Disease 2019 (JAMA) "
    ]
  },
  {
    "id": "recrYDVoINSZiwvJh",
    "Question": "Le port de gants freine-t-il la propagation de COVID-19 ?",
    "Item status": "Published",
    "Category": "Transmission",
    "Sub-category": "A propps de : COVID-19 & port de gants",
    "Source of the question": [
      "Organisation de fact-checking"
    ],
    "Background & context": "Des gants stériles, lorsqu'ils sont portés et retirés correctement, peuvent être un élément utile pour se protéger contre les maladies infectieuses. Cependant, si une personne ne porte pas correctement ses gants, cela va à l'encontre de l'objectif visé. Il est important de se rappeler que tout germe avec lequel une personne entre en contact peut se trouver sur les gants d'une autre personne, et peut ensuite être transféré sur toute autre surface que les gants touchent. Cela peut également donner aux gens un faux sentiment de sécurité lorsqu'ils portent des gants, et peut amener les gens à toucher des surfaces et des objets plus librement, puis à se toucher le visage, ce qui peut entraîner une auto-contamination par le virus. Le port de gants n'est une protection efficace que si la personne qui les porte suit les bonnes méthodes de protection. Si elles ne sont pas suivies, cela peut entraîner une contamination par un virus. \n",
    "What our experts say": "Le COVID-19 se propage principalement par gouttelettes respiratoires qui sont expulsées lorsqu'une personne infectée par COVID-19 tousse, parle fort ou éternue. Ces gouttelettes peuvent ensuite se déposer sur le visage des personnes qui les entourent, ainsi que les surfaces et les objets à proximité. Le port de gants neufs et stériles et leur retrait correct peuvent vous aider à éviter de toucher une surface ou un objet infecté à mains nues. Cependant, le virus peut se trouver sur les gants et il y a un risque de contamination si vous vous touchez le visage avec les gants. Donc, les gants ne servent à prévenir une infection que si la personne qui les porte ne touche pas son visage avec ses mains gantées et que les gants sont retirés correctement avant de se laver les mains. Il est important de se souvenir de toucher le moins de surfaces et d'objets possible si vous portez des gants afin d'empêcher la contamination de surfaces et la propagation de COVID-19 à un plus grand nombre de personnes.\nA retenir que la meilleure façon d'éviter de propager la maladie ou d'être infecté par COVID-19 est de se laver les mains nues pendant 20 secondes avec du savon et de l'eau, de maintenir une distance physique d'au moins deux mètres entre vous et les autres, et de laver et désinfecter régulièrement les surfaces de votre maison. \nPour les personnes qui s'occupent de personnes infectées par le COVID-19 ou qui sont en contact avec elles, le port de gants peut aider à s'assurer que la personne qui s'occupe d'elles ne touche pas de substances contaminées provenant du corps de la personne malade, comme le mucus provenant d'un éternuement, l'urine, le sang, les excréments ou d'autres liquides. \n",
    "Glossary Terms": [
      "recy2g3HZCckzrsKx",
      "recHFrxN3qEXqWTDa",
      "recH0gr95OweWQ1ng"
    ],
    "Topics": [
      "goutelettes",
      "lavage des mains",
      "gants",
      "prévention",
      "propagation"
    ],
    "Other resources": "1. How COVID-19 spreads ([U.S. CDC][1]) \n2. Information about the use of gloves ([WHO][2]) \n3. Information about hand hygiene ([WHO][3]) \n4. Information about COVID-19 and the use of gloves ([WHO][4])\n\n  [1]: https://www.cdc.gov/coronavirus/2019-ncov/prevent-getting-sick/how-covid-spreads.html\n  [2]: https://www.who.int/gpsc/5may/Glove_Use_Information_Leaflet.pdf\n  [3]: https://www.who.int/gpsc/5may/Hand_Hygiene_Why_How_and_When_Brochure.pdf\n  [4]: https://www.who.int/news-room/ebola-photos/detail/images/default-source/searo---images/countries/bangladesh/infographics/ask-who-social-distancing/english/wearing-gloves\n",
    "English Question": [
      "recr69VbqahSOTu3Y"
    ],
    "Variation of the answer depending on country of residence": "Non\n",
    "Does this answer vary depending on your race, ethnicity, age, sex or other demographic factors?": "Non\n",
    "Last edited (simplified)": "2020-05-17T00:07:24.000Z",
    "Last edited (experts say)": "2020-05-17T00:00:55.000Z",
    "Last modified": "2020-05-28",
    "English Glossary": [
      "recUAN8C73rkuPWX9",
      "rec5yviiSvJkufYvu",
      "rec39wm7MuK12bTI3"
    ],
    "(EN) Tags": [
      "drop",
      "droplet",
      "gloves",
      "hand washing",
      "prevention",
      "transmission",
      "spread"
    ],
    "English Category": [
      "Spread"
    ],
    "English subcategory": [
      "On: COVID-19 & wearing gloves"
    ],
    "English source": [
      "Fact-checking organization"
    ],
    "English country": [
      "Nigeria"
    ],
    "What experts say english": [
      "Wearing gloves does not directly protect against spread of the virus. COVID-19 is thought to spread primarily through small drops of moisture (respiratory droplets) that are released when a person infected with COVID-19 coughs, talks, or sneezes. Those drops can then land on the faces of people, surfaces, and items nearby. Wearing new and sterile gloves is not as effective as 20 seconds of hand washing with soap and water, but they can help you avoid touching an infected surface or item with your bare hands. Keep in mind that gloves can only prevent infection if you don't touch your face with your gloved hands, and only if you take off and dispose of the gloves correctly before washing your hands. \nIt is also important to remember to touch as few surfaces and items as possible if you are wearing gloves in order to avoid contaminating surfaces and spreading COVID-19 to more people. Remember that the best way to prevent spreading or getting infected with COVID-19 is through washing your bare hands for 20 seconds with water and soap, maintaining at least six feet of physical distance between yourself and others, and regularly washing and disinfecting surfaces in your household.\nFor people caring for, or in contact with, people who have been infected with COVID-19, wearing gloves can help make sure the caretaker doesn't touch dangerous substances that come from the sick person's body, like mucus from a sneeze, urine, blood, feces, or other fluids. "
    ],
    "Background & context english": [
      "Sterile gloves, when properly worn and properly disposed of, can be a helpful element in protecting against infectious disease. However, if a person is not wearing gloves correctly, not putting them on correctly, or not disposing of them correctly, it defeats the purpose of wearing gloves. It is important to remember that any germs that someone comes into contact with, can be on a person's gloves, and can then be transferred to any other surface that the gloves touch. It also can give people a false sense of security while wearing gloves, and can result in people touching surfaces and items more freely, then touching their faces, which can lead to self-contamination with the virus. Wearing gloves is only an effective protection when the person wearing them follows the right protective methods. If they aren't followed, it can lead to contamination with a virus. "
    ],
    "Other Resources (English)": [
      "1. How COVID-19 spreads (U.S. CDC) \n2. Outline of the evidence and considerations on medical glove use to prevent germ transmission (WHO) \n3. Hand Hygiene: Why, How & When? (WHO) \n4. Wearing-gloves (WHO)"
    ]
  },
  {
    "id": "rec5gU4AbShoWGNjF",
    "Question": "Que dit la science sur l'exposition au soleil et le COVID-19",
    "Item status": "Published",
    "Category": "Prévention",
    "Sub-category": "A propps de : COVID-19 & exposition au soleil",
    "Source of the question": [
      "Réseaux Sociaux",
      "Salle de rédaction"
    ],
    "Country question was sourced from": [
      "USA",
      "Canada"
    ],
    "Background & context": "De récents articles et études se sont intéressés au bronzage comme moyen de prévenir ou de traiter la COVID-19. Il n'a pas été prouvé que le bronzage est efficace pour combattre la COVID-19. Les rayonnements ultraviolets ou UV sont une forme de rayonnement électromagnétique, présents dans la lumière du soleil. Celle-ci émet trois types de rayonnement UV : UVA, UVB et UVC. Les UVC ont l'énergie la plus élevée et sont filtrés par l'atmosphère, de sorte qu'ils n'atteignent pas la surface de la Terre. \nCependant, les rayons UVC peuvent également êtres émis par certaines sources artificielles, telles que les ampoules désinfectantes UV, et être utilisés à l'intérieur, par exemple dans les hôpitaux, pour désinfecter les équipements et les surfaces médicales. En effet, les UVC ont la plus grande énergie des trois types de rayonnement, et leur énergie peut détruire le matériel génétique des virus. Le matériel génétique des virus comprend des informations qui peuvent contrôler la reproduction, le développement ou le comportement du virus. Mais les rayons UVC artificiels sont extrêmement dangereux pour l'Homme et ne doivent pas être utilisés en dehors d'un cadre professionnel pour désinfecter des surfaces et des objets.\nQuant à la lumière du soleil en général, même si le soleil peut tuer les germes, la désinfection des objets par la lumière du soleil ne serait pas efficace à 100 % et prendrait beaucoup de temps, et la plupart des usagers des foyers ne seraient pas en mesure de confirmer que leurs objets ont été entièrement désinfectés au cours de ce processus. Des études ont montré que la durée d'exposition au soleil nécessaire pour désinfecter des articles varie en fonction de leur taille, de leur matériau, etc. L'exposition au soleil n'est donc pas une solution recommandée pour désinfecter les articles ménagers courants. \n\n\n\n",
    "What our experts say": "S'exposer au soleil pendant une quelconque période n'empêche pas de transmettre la COVID-19 à une autre personne ou d'attraper la COVID-19 d'une autre personne. Une exposition prolongée au soleil peut être dangereuse et augmente le risque de cancer de la peau. À l'heure actuelle, l'exposition au soleil n'a pas de bienfaits pour la prévention ou le traitement de la COVID-19. \n",
    "Glossary Terms": [
      "reczZiLfjgDKGWXZp"
    ],
    "Topics": [
      "ultraviolet",
      "soleil",
      "UV"
    ],
    "Other resources": "1. A pre-print study about decontamination and COVID-19 ([medRxiv][1])\n2. WHO Mythbusters ([WHO][2])\n3. New York Times article about ongoing UVC studies on medical equipment ([New York Times][3])\n4. A study evaluating Vitamin D in the human body and its potential impacts on COVID-10 ([Aging Clinical and Experimental Research][4])\n5. A study on Vitamin D Supplementation and the prevention of acute respiratory infection ([BMJ][5])\n\n\n  [1]: https://www.medrxiv.org/content/10.1101/2020.04.02.20051409v1.full.pdf\n  [2]: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/advice-for-public/myth-busters\n  [3]: https://www.nytimes.com/2020/03/20/health/coronavirus-masks-reuse.html\n  [4]: https://link.springer.com/article/10.1007/s40520-020-01570-8\n  [5]: https://www.bmj.com/content/356/bmj.i6583\n",
    "English Question": [
      "recrNXw7eBw8czwGW"
    ],
    "Variation of the answer depending on country of residence": "Non\n",
    "Does this answer vary depending on your race, ethnicity, age, sex or other demographic factors?": "Non\n",
    "Last edited (simplified)": "2020-05-29T03:35:48.000Z",
    "Last edited (experts say)": "2020-05-29T03:10:18.000Z",
    "Last modified": "2020-06-23",
    "English Glossary": [
      "recjOgLIjiAbiBH5F"
    ],
    "(EN) Tags": [
      "ultraviolet",
      "UV",
      "sunlight"
    ],
    "English Category": [
      "Prevention"
    ],
    "English subcategory": [
      "On: COVID-19 & sunbathing"
    ],
    "English source": [
      "Newsroom",
      "Social Media"
    ],
    "English country": [
      "USA",
      "Canada"
    ],
    "What experts say english": [
      "Exposing yourself to the sun for any period of time does not prevent anyone from spreading COVID-19 to another person or catching COVID-19 from another person. Long-term exposure to sunlight can be very damaging and increase your risk of skin cancer. As of now, there is no clear benefit of sunbathing for preventing or treating COVID-19. \n"
    ],
    "Background & context english": [
      "Recent news articles and studies have focused on people sunbathing as a way to prevent or treat COVID-19. There has been no evidence that sunbathing is effective at combatting COVID-19. \nUltraviolet or UV rays are a form of electromagnetic radiation, present in sunlight. Sunlight emits three kinds of UV rays: UVA, UVB, and UVC. UVC has the highest energy and is filtered by the atmosphere so it does not reach the Earth's surface.\nHowever, UVC rays can also come from some man-made sources, such as UV sanitizing bulbs, and be used in indoor settings, such as hospitals, to disinfect medical equipment and surfaces. This is because UVC has the most energy of the three, and its energy can destroy the genetic material inside viruses. The genetic material in viruses includes information that can control the reproduction, development or behaviour of the virus. But artificial UVC rays are extremely dangerous and deadly to humans and should not be used outside of professional settings to disinfect surfaces and objects.\nAs for the general sunlight, while the sun can kill germs, disinfecting items through sunlight would not be 100% effective and would take a very long time and most household users would not be able to confirm that their items had been fully disinfected during this process. Studies have shown that there are different lengths of time of sun exposure needed for items to be disinfected depending on size, material, etc. Exposure to sunlight is therefore not a recommended solution for disinfecting routine household items. "
    ],
    "Other Resources (English)": [
      "1. Coronavirus disease (COVID-19) advice for the public: Myth busters (WHO) \n2. Ultraviolet radiation and the INTERSUN Programme (WHO) \n3. As Coronavirus Looms, Mask Shortage Gives Rise to Promising Approach (NYT) \n4. The role of vitamin D in the prevention of coronavirus disease 2019 infection and mortality (Aging Clinical and Experimental Research)\n5. Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data (BMJ)\n6. Rapid evidence summary on SARS-CoV-2 survivorship and disinfection, and a reusable PPE protocol using a double-hit process (medRxiv) \n\n"
    ]
  },
  {
    "id": "rec7DbR8cpUtj6laV",
    "Question": "La vaccination au BCG protège-t-elle contre la COVID-19 ?",
    "Item status": "Published",
    "Category": "Traitement",
    "Sub-category": "A propps de : COVID-19 & vaccins",
    "Source of the question": [
      "Réseaux Sociaux"
    ],
    "Country question was sourced from": [
      "Sénégal"
    ],
    "Background & context": "Le vaccin BGC, ou bacille Calmette-Guérin, est un vaccin contre la tuberculose (TB). Ce vaccin est utilisé dans de nombreux pays où le taux de tuberculose est élevé, afin de prévenir la maladie et d'empêcher sa propagation à grande échelle. Alors que les chercheurs en santé publique tentent de comprendre le faible nombre de cas et de décès en Afrique subsaharienne et dans certaines parties de l'Asie du Sud-Est dus au COVID-19, des hypothèses ont été émises sur le pouvoir protecteur du vaccin BCG contre le coronavirus en raison d'une corrélation entre les pays où le vaccin BCG est utilisé et le nombre de cas de COVID-19 signalés dans ces pays. La dernière étude publiée sur ce sujet le 13 mai dernier ne soutient pas l'idée que la vaccination par le BCG pendant l'enfance ait un effet protecteur contre COVID-19 à l'âge adulte. D'autres études sont en cours.\n",
    "What our experts say": "De nombreuses études explorent le lien entre les politiques de vaccination par le BCG dans divers pays et le nombre relativement faible de cas et de décès dus à la COVID-19. La dernière étude menée en Israël et publiée sur ce sujet le 13 mai ne soutient pas l'idée que la vaccination par le BCG pendant l'enfance ait un effet protecteur contre la COVID-19 à l'âge adulte. L'OMS a publié une note à ce sujet qui indique qu'en l'absence de preuves, l'OMS ne recommande pas la vaccination par le BCG pour la prévention de la COVID-19. D'autres études sont en cours.\n",
    "Glossary Terms": [
      "recF5ZskHxC3iLoRg",
      "rec6TkHKY7sNXMmZV"
    ],
    "Topics": [
      "prévention",
      "vaccin"
    ],
    "Other resources": "1. Research paper: SARS-CoV-2 rates in BCG-vaccinated and -unvaccinated young adults ([JAMA][1]) \n2. Scientific brief: BCG vaccination and COVID-19 ([WHO][2]) \n\n  [1]: https://jamanetwork.com/journals/jama/fullarticle/2766182\n  [2]: https://www.who.int/news-room/commentaries/detail/bacille-calmette-guérin-(bcg)-vaccination-and-covid-19\n",
    "English Question": [
      "recCC7GhsX2CKZJbs"
    ],
    "Variation of the answer depending on country of residence": "Non\n",
    "Does this answer vary depending on your race, ethnicity, age, sex or other demographic factors?": "Non\n",
    "Last edited (simplified)": "2020-05-14T05:04:31.000Z",
    "Last edited (experts say)": "2020-05-14T05:05:28.000Z",
    "Last modified": "2020-05-27",
    "English Glossary": [
      "rec9SYUCp1ULDd0UL",
      "recUx8LCQGkRdxG3B"
    ],
    "(EN) Tags": [
      "prevention",
      "vaccine",
      "BCG"
    ],
    "English Category": [
      "Treatment"
    ],
    "English subcategory": [
      "On: COVID-19 & vaccines"
    ],
    "English source": [
      "Social Media"
    ],
    "English country": [
      "Senegal"
    ],
    "What experts say english": [
      "Multiple studies are exploring the link between BCG vaccination policies in various countries, and the relatively lower number of COVID-19 cases and deaths in those countries. Recent studies published do not support the idea that BCG vaccination in childhood is a cause of protection against COVID-19 in adulthood. The World Health Organization (WHO) has published a note on this topic that stated that in the absence of evidence, WHO does not recommend BCG vaccination for the prevention of COVID-19. More studies are underway. \n\nUPDATED: July 11, 2020: A recent study published in the Proceedings of the National Academy of Sciences (U.S.) noted that after they accounted for differences in variables like income, age distribution, and access to health services, countries with higher BCG vaccination rates had lower peak mortality rates from COVID-19. However, though there is an association between BCG vaccination and reduced severity of COVID-19 observed in this epidemiological study, it does not mean that there is sufficient enough evidence to consider BCG vaccination a cause of protection from severe COVID-19. There is not enough evidence to support whether or not BCG vaccines can offer protection against severe COVID-19 symptoms and death, and we will continue to update this answer as study results targeting the vaccine  are published."
    ],
    "Background & context english": [
      "The BGC vaccine, or the bacille Calmette-Guerin vaccine, is a vaccine for tuberculosis (TB) disease. This vaccine is used in many countries that have high rates of tuberculosis in order to prevent the disease from spreading. As public health researchers try and understand the low case numbers and death count in sub-Saharan Africa and parts of South-East Asia from COVID-19, hypotheses have emerged about the protective power of the BCG vaccine against the coronavirus because of a correlation between countries where the BCG vaccine is widely used and the low number of COVID-19 cases reported in those countries. Recent studies published on this topic do not support the idea that BCG vaccination in childhood has a protective effect against COVID-19 in adulthood. More studies are underway as it's still not clear yet how the BCG vaccine interacts with the virus that causes COVID-19.\n"
    ],
    "Other Resources (English)": [
      "1. SARS-CoV-2 Rates in BCG-Vaccinated and Unvaccinated Young Adults (JAMA) \n2. Bacille Calmette-Guérin (BCG) vaccination and COVID-19 (WHO) \n3. BCG vaccine protection from severe coronavirus disease 2019 (COVID-19) (PNAS) \n"
    ]
  }
]